Potency of three opiate antagonists to reverse the inhibitory activity of dynorphin, enkephalins and opioid-like alkaloids on the guinea pig ileum.

[1]  J. Huidobro-Toro,et al.  Application of an irreversible opiate antagonist (β-FNA, β-funal-trexamine) to demonstrate dynorphin selectivity for K-opioid sites , 1982 .

[2]  C. Chavkin,et al.  Dynorphin is a specific endogenous ligand of the κ opioid receptor Science, 215 (1982) 413–415 , 1982, Pain.

[3]  J. Huidobro-Toro,et al.  Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum. , 1982, The Journal of pharmacology and experimental therapeutics.

[4]  Y. Watanabe,et al.  The choice of opiate receptor subtype by neo-endorphins. , 1982, European journal of pharmacology.

[5]  S. Tachibana,et al.  Isolation and structure of dynorphin, an opioid peptide, from porcine duodenum , 1982, Nature.

[6]  A. Sawa,et al.  Evidence that dynorphin-(1–13) acts as an agonist on opioid κ-receptors , 1982 .

[7]  C. Chavkin,et al.  Dynorphin is a specific endogenous ligand of the kappa opioid receptor. , 1982, Science.

[8]  J. Huidobro-Toro,et al.  Dynorphin: Interaction with putative kappa-sites on the guinea pig ileum , 1982 .

[9]  C. Pert,et al.  Dynorphins: Similar relative potencies on μ-, δ- and κ-opiate receptors , 1981 .

[10]  A Goldstein,et al.  Specific receptor for the opioid peptide dynorphin: structure--activity relationships. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Schulz,et al.  The preference of putative pro-enkephalins for different types of opiate receptors. , 1981, Life sciences.

[12]  M. Ueki,et al.  Rabbit vas deferens: A specific bioassay for opioid κ-receptor agonists , 1981 .

[13]  A. Herz,et al.  Demonstration and distribution of an opiate binding site in rat brain with high affinity for ethylketocyclazocine and SKF 10,047. , 1981, Biochemical and biophysical research communications.

[14]  J. Huidobro-Toro,et al.  Calcium antagonism of the inhibitory effect of normorphine on the ileum of the morphine-tolerant and nontolerant guinea pig. , 1981, The Journal of pharmacology and experimental therapeutics.

[15]  H. Loh,et al.  Dynorphin interaction at the κ-opiate site , 1981 .

[16]  C. Chavkin,et al.  Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexus , 1981, Nature.

[17]  D. L. Larson,et al.  The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone. , 1981, European Journal of Pharmacology.

[18]  T. Petcher,et al.  Bremazocine: a potent, long-acting opiate kappa-agonist. , 1980, Life sciences.

[19]  R. Schulz,et al.  Highly specific opiate receptors for dynorphin-(1-13) in the mouse vas deferens. , 1980, European journal of pharmacology.

[20]  D. L. Larson,et al.  A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. , 1980, Journal of medicinal chemistry.

[21]  L. Hood,et al.  Dynorphin-(1-13), an extraordinarily potent opioid peptide. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Musacchio,et al.  Electrically induced opiate-like inhibition of the guinea-pig ileum: cross-tolerance to morphine. , 1978, The Journal of pharmacology and experimental therapeutics.

[23]  John Hughes,et al.  Endogenous opioid peptides: multiple agonists and receptors , 1977, Nature.

[24]  G. Henderson,et al.  In vitro pharmacology of the opioid peptides, enkephalins and endorphins. , 1977, European journal of pharmacology.

[25]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[26]  L. Terenius,et al.  ASSESSMENT IN THE GUINEA‐PIG ILEUM AND MOUSE VAS DEFERENS OF BENZOMORPHANS WHICH HAVE STRONG ANTINOCICEPTIVE ACTIVITY BUT DO NOT SUBSTITUTE FOR MORPHINE IN THE DEPENDENT MONKEY , 1975, British journal of pharmacology.

[27]  F. Leslie,et al.  EFFECT OF MORPHINE ON ADRENERGIC TRANSMISSION IN THE MOUSE VAS DEFERENS. ASSESSMENT OF AGONIST AND ANTAGONIST POTENCIES OF NARCOTIC ANALGESICS , 1975, British journal of pharmacology.

[28]  A. Watt,et al.  The effects of adrenaline, noradrenaline and isoprenaline on inhibitory α‐ and β‐adrenoceptors in the longitudinal muscle of the guinea‐pig ileum , 1970, British journal of pharmacology.

[29]  L. N. Balaam,et al.  Biostatistics -- An Introductory Text , 1965 .

[30]  Ş. Kaymakçalan,et al.  RESPONSE OF THE ISOLATED INTESTINE OF NORMAL AND MORPHINE-TOLERANT RATS TO MORPHINE AND NALORPHINE. , 1964, Archives internationales de pharmacodynamie et de therapie.

[31]  H. Schild,et al.  SOME QUANTITATIVE USES OF DRUG ANTAGONISTS , 1997, British journal of pharmacology and chemotherapy.